ranibizumab ophthalmic(ranibizumab 1.65 mg/0.165 mL intravitreal syringe), Intravitreal, monthly, PRN for other: see indication, Indication: macular degeneration
generic
token
 {
  "is_medication": true,
  "brand_name": null,
  "generic_name": "ranibizumab ophthalmic",
  "active_ingredients": [
    {
      "name": "ranibizumab",
      "strength": 1.65,
      "strength_unit": "mg"
    }
  ],
  "prn": true,
  "form": "Intravitreal",
  "route": "Ophthalmic",
  "systemic": false,
  "doses": null,
  "daily_frequency": "1/30",
  "total_daily_dose": null,
  "total_daily_dose_unit": null}